amgen version drug call neupogen garner
big sale sinc approv sale u.s. last
februari amgen said two patent cover drug
process make
chugai approv sell version drug
japan yet sought approv u.s. amgen
spokeswoman said declin discuss amgen reason
bring legal action time
offici chugai base tokyo could
reach comment
